Medicare Enrolled
Dr. Shahram Khalid, M.D
Neurology · Waxahachie, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Khalid from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Khalid?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Khalid
Dr. Shahram Khalid is a neurology specialist in Waxahachie, TX, with 16 years of NPI registration. Based on federal Medicare data, Dr. Khalid performed 2,320 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Khalid received a total of $6,691 from 51 pharmaceutical and/or device companies across 363 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Khalid is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years of NPI registration
▲ Top 18% volume in TX
$6,691 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,320
Medicare services
Top 18% in TX for neurology
Not available
Unique patients (not deduplicated)
$112
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
445 | $61 | $135 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
443 | $86 | $179 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
260 | $132 | $300 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
210 | $120 | $260 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
186 | $115 | $218 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
159 | $61 | $135 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
109 | $91 | $175 |
| New patient office visit, complex (60-74 min) | 103 | $146 | $261 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
84 | $47 | $120 |
| Video EEG monitoring, 12-26 hours A 12 to 26-hour test that records brain wave activity while simultaneously capturing video of the patient's behavior. |
53 | $806 | $2,000 |
| Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | 51 | $185 | $415 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
26 | $84 | $163 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
26 | $155 | $395 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
23 | $39 | $86 |
| Psychological test administration, first 30 minutes A technician administers psychological or neuropsychological testing for the first 30 minutes. |
22 | $26 | $85 |
| Continuous EEG brain wave monitoring A test that records electrical activity in the brain over an extended period. It is used to monitor brain function continuously. |
21 | $203 | $500 |
| Vestibular function test with thermal irrigation A test that assesses balance by irrigating both ears with warm and cool fluids to evaluate inner ear function. |
19 | $31 | $100 |
| Balance testing with recording A procedure to evaluate balance function by recording the results during testing. |
19 | $83 | $155 |
| Video EEG monitoring, 61-84 hours This procedure involves monitoring brain wave activity using an electroencephalogram (EEG) while simultaneously recording video for a duration of 61 to 84 hours. A healthcare professional reviews the data and provides a report. |
19 | $243 | $650 |
| Assessment of emotional or behavioral problems An evaluation to identify and understand emotional or behavioral issues. This process involves reviewing symptoms and behaviors to determine the nature of the concerns. |
15 | $3 | $8 |
| Emergency department visit, low level of medical decision making An emergency department visit for a patient requiring a low level of medical decision making. |
15 | $51 | $92 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
12 | $211 | $525 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$6,691
Total received (2018-2024)
Avg $956/year across 7 years
Top 35% in TX for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
363
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,827
2023
$1,757
2022
$1,383
2021
$628
2020
$440
2019
$564
2018
$92
Payments by company (2024)
ABBVIE INC.
$210
UCB, Inc.
$201
Novartis Pharmaceuticals Corporation
$187
PFIZER INC.
$147
TG Therapeutics, Inc.
$129
Genentech USA, Inc.
$114
Amneal Pharmaceuticals LLC
$113
EMD Serono, Inc.
$98
Tonix Medicines, Inc.
$69
Boston Scientific Corporation
$64
Eisai Inc.
$55
Biogen, Inc.
$55
Abbott Laboratories
$52
Lundbeck LLC
$50
SK Life Science, Inc.
$47
Lilly USA, LLC
$39
GE HEALTHCARE
$36
ARGENX US, INC.
$33
HOSPIRA, INC.
$30
MITSUBISHI TANABE PHARMA AMERICA, INC.
$22
NS Pharma, Inc.
$20
BIOTRONIK NRO, Inc.
$19
Takeda Pharmaceuticals U.S.A., Inc.
$19
Medtronic, Inc.
$17
Top 3 companies account for 32.7% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$593
Novartis Pharmaceuticals Corporation
$581
US WorldMeds, LLC
$579
UCB, Inc.
$461
Biogen, Inc.
$404
Amneal Pharmaceuticals LLC
$309
SK Life Science, Inc.
$291
Teva Pharmaceuticals USA, Inc.
$257
PFIZER INC.
$242
Genentech USA, Inc.
$241
ARGENX US, INC.
$217
IMPEL PHARMACEUTICALS INC.
$161
Lilly USA, LLC
$151
GENZYME CORPORATION
$142
Lundbeck LLC
$137
Abbott Laboratories
$130
MDD US Operations, LLC
$130
TG Therapeutics, Inc.
$129
Amgen Inc.
$117
EMD Serono, Inc.
$98
ACADIA Pharmaceuticals Inc
$94
Boston Scientific Corporation
$86
GE HEALTHCARE
$81
AbbVie Inc.
$75
JAZZ PHARMACEUTICALS INC.
$74
Celgene Corporation
$74
Tonix Medicines, Inc.
$69
Biohaven Pharmaceutical Holding Company Ltd.
$66
Neurocrine Biosciences, Inc.
$66
UPSHER-SMITH LABORATORIES LLC
$62
Alexion Pharmaceuticals, Inc.
$58
Eisai Inc.
$55
Biohaven Pharmaceuticals, Inc.
$55
Avion Pharmaceuticals
$49
Takeda Pharmaceuticals U.S.A., Inc.
$36
HOSPIRA, INC.
$30
Grifols USA, LLC
$27
CATALYST PHARMACEUTICALS, INC.
$25
Kyowa Kirin, Inc.
$23
Sunovion Pharmaceuticals Inc.
$22
GE HealthCare
$22
MITSUBISHI TANABE PHARMA AMERICA, INC.
$22
NS Pharma, Inc.
$20
ARBOR PHARMACEUTICALS, INC.
$19
BIOTRONIK NRO, Inc.
$19
Avanir Pharmaceuticals, Inc.
$18
Medtronic, Inc.
$17
Scilex Pharmaceuticals Inc.
$17
Neurelis, Inc.
$16
Mylan Specialty L.P.
$13
Supernus Pharmaceuticals, Inc.
$11
Top 3 companies account for 26.2% of all-time payments
Associated products mentioned in payments ›
ADUHELM · AIMOVIG · AJOVY · AMYVID · APOKYN · AUBAGIO · AUSTEDO · Aimovig · Austedo XR · BRIUMVI · Briviact · DUOPA · Dhivy · Dymista · EMGALITY · Enspryng · FIRDAPSE · GAMMAGARD · Gamunex-C · HYQVIA · Horizant · INFINITY · INGREZZA · INTELLIS ADAPTIVESTIM · Infinity DBS Pulse Generators · KESIMPTA · KYNMOBI · Leqembi · MYOBLOC · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · Ocrevus · PAXLOVID · Prospera · QULIPTA · RADICAVA · RYTARY · Rystiggo · SKYCLARYS · SOLIRIS · SUNOSI · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · VALTOCO · VILTEPSO · VYEPTI · VYVGART · VYVGART HYTRULO · Vercise · XADAGO · Xadago · ZEMBRACE SYMTOUCH · ZEPOSIA · ZTLido
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Neurologists in nearby ZIP areas
12
County median income
$95,898
Nearest hospital to ZIP centroid (approximate)
BAYLOR SCOTT & WHITE MEDICAL CENTER- WAXAHACHIE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Khalid is a clinical cardiology specialist, with above-average Medicare volume (top 18% in TX), with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Khalid experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Khalid performed 445 office visit, established patient (20-29 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Khalid receive payments from pharmaceutical companies?
Yes. Dr. Khalid received a total of $6,691 from 51 companies across 363 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Khalid's costs compare to other neurologists in Waxahachie?
Dr. Khalid's average Medicare payment per service is $112. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Khalid) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Waxahachie
Browse neurologists in Waxahachie ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in TX
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in TX
Which TX neurologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
US WorldMeds, LLC Payments to Doctors
See all physicians who received payments from US WorldMeds, LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology